Survival of patients from the diagnosis of t-MDS and t-AML after autologous stem cell transplantation—review of the literature
| Survival (mo) . | Died of t-MDS (no. of patients) . | Died of t-AML (no. of patients) . | Still alive (no. of patients) . |
|---|---|---|---|
| 0-6 | 24 | 8 | 5 |
| 7-12 | 12 | 3 | 5 |
| 13-18 | 1 | 2 | — |
| >18 | 2 | — | 114-150 |
| Total | 39 | 13 | 21 |
| Survival (mo) . | Died of t-MDS (no. of patients) . | Died of t-AML (no. of patients) . | Still alive (no. of patients) . |
|---|---|---|---|
| 0-6 | 24 | 8 | 5 |
| 7-12 | 12 | 3 | 5 |
| 13-18 | 1 | 2 | — |
| >18 | 2 | — | 114-150 |
| Total | 39 | 13 | 21 |
Three of these patients presented a normal karyotype, another 5 patients a del(7q) or −7, in 3 cases as the only aberration, whereas 1 patient presented a del(11q).